from

Lyell Immunopharma Presents New Clinical Data from Ongoing Trial of Ronde-Cel Showing High Rates of Durable Complete Responses in Patients with Large B-cell Lymphoma at the 67th ASH Annual Meeting and Exposition

93% overall response and 76% complete response rates with median progression-free survival of 18 months in patients with large B-cell…

21 hours ago

Wave Life Sciences to Announce Interim Data from the Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity on Monday, December 8, 2025

December 07, 2025 16:00 ET  | Source: Wave Life Sciences USA, Inc. CAMBRIDGE, Mass., Dec. 07, 2025 (GLOBE NEWSWIRE) --…

21 hours ago

TScan Therapeutics Announces Positive Updated Data from the ALLOHA Phase 1 Heme Trial at the 67th American Society of Hematology Annual Meeting and Exposition

December 06, 2025 17:30 ET  | Source: TScan Therapeutics, Inc. Treatment arm continues to demonstrate favorable relapse-free survival (HR=0.50; p=0.23)…

2 days ago

Fulcrum Therapeutics Announces Positive Initial Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting

December 06, 2025 17:30 ET  | Source: Fulcrum Therapeutics, Inc. ― Clear dose-response observed, with a robust and clinically meaningful…

2 days ago

Etaily lands strategic investment from Japans SMBC – bringing total funding to $24M for Social Commerce enablement platform

Manila, Dec. 04, 2025 (GLOBE NEWSWIRE) -- etaily, the Philippines’ digital-native retail platform, has secured new strategic investments led by…

4 days ago

4D Paths Physics-Inspired QPOR Platform Predicts Neoadjuvant Chemotherapy Response from Routine Biopsy Images in Early-Stage Triple-Negative Breast Cancer from Phase II TBCRC-030 Trial

NEWTON, Mass., Dec. 03, 2025 (GLOBE NEWSWIRE) -- 4D Path, a company dedicated to personalizing cancer care through a novel,…

5 days ago

The Martech Reset: Lessons from 2025 That Will Shape How CMOs Invest in 2026, opines Kalpit Jain, CEO, Netcore Cloud

MUMBAI, India, Dec. 2, 2025 /PRNewswire/ -- 2025 overwhelmed marketers: too many tools, too much complexity, too little speed. Every…

6 days ago

Receipt of Delinquency Notification from Nasdaq

Singapore, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL) (the “Company”), today announced that it has…

7 days ago

Anabolic Steroids Alternatives: Muscle Building Supplements from CrazyBulk | Most Selling Muscular Endurance Supplements Bodybuilders Use For Peak Performance & Strength Building in 2025

New York City, Nov. 29, 2025 (GLOBE NEWSWIRE) -- November 28, 2025, CrazyBulk, a leading provider of Anabolic steroid alternatives,…

1 week ago

GGPick.com Launches as the Ultimate Marketplace for Digital Savings, from Streaming Subscriptions to Game Keys

LONDON, UK, Nov. 27, 2025 (GLOBE NEWSWIRE) -- As the digital entertainment landscape expands, consumers face a growing financial burden…

2 weeks ago